Skip to main content

Find Clinical Trials

Home
Conditions
Nasopharyngeal Diseases

Clinical trial condition

Nasopharyngeal Diseases

Explore clinical trials studying Nasopharyngeal Diseases. Study availability and eligibility vary by location and protocol.

503 public trials 163 recruiting studies

Refine in advanced search Browse all conditions

Nasopharyngeal Diseases trial results

Completed

The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients

NCT03981224

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations: Not specified

View Trial Details

Completed

Plasma EBV DNA Monitoring in Post-treatment NPC Patients

NCT03973723

Conditions: Carcinoma, EBV, Head and Neck Neoplasms, +14 more
Locations: Taichung Veterans General Hospital Taichung, Taiwan

View Trial Details

Completed

Photodynamic Therapy in Treating Patients With Premalignant or Early Stage Head and Neck Tumors

NCT00978081

Conditions: Head and Neck Cancer, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, +18 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC

NCT02012062

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Fudan University Shanghai Cancer Center Shanghai, China

View Trial Details

Completed

Hepatic Artery Infusion Pump for NPC Liver Metastases

NCT03876574

Conditions: Carcinoma, Head and Neck Neoplasms, Liver, +16 more
Locations: Not specified

View Trial Details

Completed

Phase III: Assess Conventional RT w/ Conventional Plus Accelerated Boost RT in the Treatment of Nasopharyngeal CA

NCT00535795

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: KFSH&RC Riyadh, Saudi Arabia

View Trial Details

Completed

A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer

NCT00603915

Conditions: Head and Neck Neoplasms, Nasopharyngeal Cancer, Nasopharyngeal Diseases, +8 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients

NCT03839602

Conditions: Carcinoma, Early-stage Nasopharyngeal Carcinoma, Head and Neck Neoplasms, +14 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Target Volume Delineation After NACT in LA-NPCarcinoma Patients Treated With NACT+ CCRT

NCT03283293

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Completed

Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)

NCT01392235

Conditions: Carcinoma, Head and Neck Neoplasms, Metastatic Nasopharyngeal Carcinoma, +13 more
Locations: Department of Medical Oncology, Cancer Center, Sun Yet-sen University Guangzhou, Guangdong, China

View Trial Details